Chemical mapping of tulobuterol in transdermal tapes using Microscopic Laser Raman Spectroscopy

Pharmazie

Volumn 64, Issue 3, 2009, Pages 166-171

  Sakamoto, Tomoaki ^a   Matsubara, T ^b   Sasakura, D ^b   Takada, Y ^c   Fujimaki, Y ^d   Aida, K ^c   Miura, T ^b   Terahara, T ^c   Higo, N ^c   Kawanishi, T ^a   Hiyama, Y ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b Bruker Optics Inc   (United States)

^c HISAMITSU PHARMACEUTICAL CO INC   (Japan)

^d TOKYO METROPOLITAN INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TULOBUTEROL; ACRYLIC ACID DERIVATIVE; ANTIASTHMATIC AGENT; DRUG DERIVATIVE; RUBBER; TERBUTALINE;

ACCURACY; ARTICLE; CONTROLLED STUDY; CRYSTAL; DRUG DETERMINATION; DRUG DISTRIBUTION; HUMAN; IN VITRO STUDY; MICROSCOPIC LASER RAMAN SPECTROSCOPY; MICROSCOPY; NONHUMAN; QUALITY CONTROL; RAMAN SPECTROMETRY; SKIN PERMEABILITY; CHEMICAL MODEL; CRYSTALLIZATION; INTRADERMAL DRUG ADMINISTRATION;

ACRYLATES; ADMINISTRATION, CUTANEOUS; ANTI-ASTHMATIC AGENTS; CRYSTALLIZATION; MODELS, CHEMICAL; QUALITY CONTROL; RUBBER; SPECTRUM ANALYSIS, RAMAN; TERBUTALINE;

EID: 65349118749     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2008.8217     Document Type: Article

References (17)

1. Deely C, Spragg R, Threlfall T (1991) A Comparison of Fourier transform infrared and near-infrared Fourier transform Raman spectroscopy for quantitative measurements: an application in polymorphism. Spectrochim Acta 47: 1217-1223.
2. Falcon J, Berglund K (2004) In situ monitoring of antisolvent addition crystallization with principal components analysis of Raman spectra. Cryst Growth Des 4: 457-463.
3. Ferrari E, Davey R (2004) Solution-mediated transformation of α to β 1-glutamic acid: rate enhancement due to secondary nucleation. Cryst Growth Des 4: 1061-1068.
4. Findlay P, Bugay D (1998) Utilization of Fourier transform-Raman spectroscopy for the study of pharmaceutical crystal forms. J Pharm Biomed Anal 16: 921-930.
5. Horiguchi T, Kondo R, Miyazaki J, Torigoe H, Tachikawa S (2004) Clinical evaluation of tulobuterol patch in patients with mild or moderate persistent bronchial asthma-effects of long-term treatment on airway inflammation and hypersensitivity. Nihon Kokyuki Gakkai Zasshi 42: 132-137.
6. Hu Y, Liang J, Myerson A, Taylor LS (2005) Crystallization monitoring by Raman spectroscopy: simultaneous measurement of desupersaturation profile and polymorphic form in flufenamic acid systems. Ind Eng Chem Res 44: 1233-1240.
7. Iikura Y, Uchiyama H, Akimoto K, Ebisawa M, Sakaguchi N, Tsubaki T, Ishizu H, Kabayama H, Yagi K, Miura K (1995) Pharmacokinetics and pharmacodynamics of the tulobuterol patch, HN-078, in childhood asthma. Ann Allergy Asthma Immunol 74: 147-151.
8. Langkilde F, Sjöblom J, Tekenbergs-Hjelte L, Mrak A (1997) Quantitative FT-Raman analysis of two crystal forms of a pharmaceutical compound. J Pharm Biomed Anal 15: 687-696.
9. Murphy BM, Prescott SW, Larson I (2005) Measurement of lactose crystallinity using Raman spectroscopy. J Pharm Biomed Anal 38: 186-190.
10. Nørgaard L, Hahn MT, Knudsen LB, Farhat IA, Engelsen SB (2005) Multivariate near infrared and Rama spectroscopic quantifications of the crystallinity of lactose in whet permeate powder. Int Dairy J 15: 1261-1270.
11. Ono T, ter Horst J, Jansens P (2004) Quantitative measurement of the polymorphic transformation of l-glutamic acid using in-situ Raman spectroscopy. Cryst Growth Des 4: 465-469.
12. Raghavan SL, Trividic A, Davis AF, Hadgraft J (2001) Crystallization of hydrocortisone acetate: influence of polymers. Int J Pharm 212: 213-221.
13. Schöll J, Bonalumi D, Vicum L, Mazzotti M (2006) In situ monitoring and modeling of the solvent-mediated polymorphic transformation of l-glutamic acid. Cryst Growth Des, 6: 881-891.
14. Starbuck C, Spartails A, Wai L, Wang J, Fernandez P, Lindemann C, Zhou G, Ge Z (2002) Process optimization of a complex pharmaceutical polymorphic system via in situ Raman spectroscopy. Cryst Growth Des 2: 515-522.
15. Taylor LS, Zografi G (1998) Quantitative analysis of crystallinity using FT-Raman spectroscopy. Pharm Res 15: 755-761.
16. Uematsu T, Nakano M, Kosuge K, Kanamaru M, Nakashima M (1993) The pharmacokinetics of the beta 2-adrenocepter agonist, tulobuterol given transdermally and by inhalation. Eur J Clin Pharmacol 44: 361-364.
17. Wang F, Wachter J, Antosz F, Berglund K (2000) An investigation of solvent-mediated polymorphic transformation of progesterone using in situ Raman spectroscopy. Org Proc Res Dev, 4: 391-395.